Cryptic splice mutation in the fumarate hydratase gene in patients with clinical manifestations of Hereditary Leiomyomatosis and Renal Cell Cancer
Human Molecular Genetics · 2023
DOI: 10.1093/hmg/ddad131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2023. Verfasst von Daniel R Crooks und 15 weiteren Autor:innen. Beteiligte Einrichtung: Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892, United States. Hauptthemen laut MEDLINE: Kidney Neoplasms, Carcinoma, Renal Cell, Skin Neoplasms, Uterine Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Intramural NIH HHS, Intramural Research Program of NCI-CCR.
Abstract (Originalsprache)
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is an autosomal dominant condition characterized by the development of cutaneous and uterine leiomyomas and risk for development of an aggressive form of papillary renal cell cancer. HLRCC is caused by germline inactivating pathogenic variants in the fumarate hydratase (FH) gene, which encodes the enzyme that catalyzes the interconversion of fumarate and L-malate. We utilized enzyme and protein mobility assays to evaluate the FH enzyme in a cohort of patients who showed clinical manifestations of HLRCC but were negative for known pathogenic FH gene variants. FH enzyme activity and protein levels were decreased by 50% or greater in three family members, despite normal FH mRNA expression levels as measured by quantitative PCR. Direct Nanopore RNA sequencing demonstrated 57 base pairs of retained intron sequence between exons 9 and 10 of polyadenylated FH mRNA in these patients, resulting in a truncated FH protein. Genomic sequencing revealed a heterozygous intronic alteration of the FH gene (chr1: 241498239 T/C) resulting in formation of a splice acceptor site near a polypyrimidine tract, and a uterine fibroid obtained from a patient showed loss of heterozygosity at this site. The same intronic FH variant was identified in an unrelated patient who also showed a clinical phenotype of HLRCC. These data demonstrate that careful clinical assessment as well as biochemical characterization of FH enzyme activity, protein expression, direct RNA sequencing, and genomic DNA sequencing of patient-derived cells can identify pathogenic variants outside of the protein coding regions of the FH gene.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892, United States.
- RNA Metabolism and Epitranscriptomics Unit, Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD 20892, United States.
- Chemical Biology Laboratory, National Cancer Institute, 1050 Boyles St., Frederick, MD 21072, United States.
- Basic Science Program, Frederick National Laboratory for Cancer Research, 1050 Boyles St. Frederick, MD 21701, United States.
- CCR Collaborative Bioinformatics Resource (CCBR), Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., 1050 Boyles St., Frederick, MD 21072, United States.
- Translational Surgical Pathology, Laboratory of Pathology Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, United States.
ORCID-Profile: William Marston Linehan
Förderung
- NCI NIH HHS
- Intramural NIH HHS
- Intramural Research Program of NCI-CCR
- Pamela Anne Cafritz Renal Cell Carcinoma Award
- National Cancer Institute
- National Institutes of Health
- American Cancer Society
- Department of Health and Human Services
Zitieren
APA
Crooks, D. R., Cawthon, G. M., Fitzsimmons, C. M., Perez, M., Ricketts, C. J., Vocke, C. D., Yang, Y., Middelton, L., Nielsen, D., Schmidt, L. S., Tandon, M., Merino, M. J., Ball, M. W., Meier, J. L., Batista, P. J., & Linehan, W. M. (2023). Cryptic splice mutation in the fumarate hydratase gene in patients with clinical manifestations of Hereditary Leiomyomatosis and Renal Cell Cancer. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddad131
Vancouver
Crooks DR, Cawthon GM, Fitzsimmons CM, Perez M, Ricketts CJ, Vocke CD, et al. Cryptic splice mutation in the fumarate hydratase gene in patients with clinical manifestations of Hereditary Leiomyomatosis and Renal Cell Cancer. Human Molecular Genetics. 2023. doi:10.1093/hmg/ddad131
BibTeX
@article{Crooks2023,
author = {Crooks, Daniel R and Cawthon, Geetha Mariah and Fitzsimmons, Christina M and Perez, Minervo and Ricketts, Christopher J and Vocke, Cathy D and Yang, Ye and Middelton, Lindsay and Nielsen, Debbie and Schmidt, Laura S and Tandon, Mayank and Merino, Maria J and Ball, Mark W and Meier, Jordan L and Batista, Pedro J and Linehan, William Marston},
title = {Cryptic splice mutation in the fumarate hydratase gene in patients with clinical manifestations of Hereditary Leiomyomatosis and Renal Cell Cancer},
journal = {Human Molecular Genetics},
year = {2023},
doi = {10.1093/hmg/ddad131}
}
EUVIMED